Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material which is copyrighted by the American Medical Association (AMA). You are forbidden to download the files unless you read, agree to and abide by the provisions of the copyright statement. Read the copyright statement now (you will be linked back to here).

 

National Government Services, Inc.
 Medicare Monthly Review Part A and B
A Combined Part A and Part B Newsletter
MMR-2008 03B, March 2008

Part B New Jersey and New York Retired Local Coverage Determinations

National Government Services for New Jersey and New York Medicare Part B will retire the Local Coverage Determinations (LCDs) listed below, effective February 29, 2008. .

For dates of service on or after March 1, 2008, please refer to the Drugs and Biologicals, Coverage of, For Label and Off-Label Uses (L25820) LCD and related articles regarding coverage of these and other drugs.

LCD Title

New Jersey LCD Number

New York LCD Number

Carboplatin (Paraplatin, Paraplatin-AQ)

L4633

L8210

Cisplatin (e.g., Platinol®, Platinol-AQ)

L4649

L3655

Doxorubicin HCL Liposome Injection (e.g., Doxil)

L11613

L12722

Etoposide (VePesid, VP-16)

L4650

L7506

Fulvestrant (e.g., Faslodex®)

L11598

L11622

GM-CSF (Leukine, Sargramostim)

L3851

L8093

Infliximab (e.g., Remicade)

L3695

L3083

Irinotecan Hydrochloride (e.g., Camptosar)

L11606

L3100

Oxaliplatin (Eloxatin)

L13743

L14240

Paclitaxel (e.g., Taxol®/Abraxane™)

L4663

L6976

Sentinel Lymph Node Biopsy

L4015

L3473

Vinorelbine Tartrate (e.g., Navelbine®)

L11609

L3485